Mechanistically, we found that IL-1β is a key downstream gene affected by AK4, and AK4 may promote IL-1β release by activating the NLRP3 inflammasome signaling pathway binding with nicotinamide nucleotide transhydrogenase (NNT), thereby promoting invasion, migration, and chemoresistance of tumor cells. Here, IL1B is linked to neoplasm.